Product Information
HEARTBURN RELIEF 20 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1382 per EA under NDC 00904578051. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 25, 2006.
Strength
20 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904578051
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077351FDA Approved
9/25/2006
On Market Since
9/29/2006
Pharmacological Classes
Price Statistics
The NADAC for HEARTBURN RELIEF 20 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 20.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1382 per EA |
|---|---|
| All-time high | $0.2029 (Nov 11, 2015) |
| All-time low | $0.1341 (Jun 19, 2024) |
| 52-week high | $0.1480 |
| 52-week low | $0.1382 |
| Median price | $0.1571 |
| Average price | $0.1608 |
| Largest weekly change | -12.6% (Nov 18, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 25 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEARTBURN RELIEF 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HEARTBURN RELIEF 20 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1382 per EA (NDC 00904578051), effective Sep 30, 2026.
How has the price of HEARTBURN RELIEF 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for HEARTBURN RELIEF 20 MG TABLET has declined 20.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HEARTBURN RELIEF 20 MG TABLET?
Since Nov 28, 2013, the NADAC for HEARTBURN RELIEF 20 MG TABLET has ranged from a low of $0.1341 (Jun 19, 2024) to a high of $0.2029 (Nov 11, 2015), with a median of $0.1571 per EA.
Are there cheaper alternatives to HEARTBURN RELIEF 20 MG TABLET?
Yes. 25 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FAMOTIDINE 20 MG TABLET, is $0.0289 per EA — about 79% below HEARTBURN RELIEF 20 MG TABLET.
Who manufactures HEARTBURN RELIEF 20 MG TABLET?
HEARTBURN RELIEF 20 MG TABLET (NDC 00904578051) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.